Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.
This study has been completed.
Information provided by:
First received: August 30, 2005
Last updated: December 29, 2006
Last verified: December 2006
Evaluate long-term safety and efficacy of pregabalin in patients with chronic neuropathic pain.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Chronic Neuropathic Pain.|
Resource links provided by NLM:
Further study details as provided by Pfizer:
Contacts and Locations